US 4,536,398 A · Antiviral agents

Abstract

Disclosed is an antiviral agent comprising as an active component a substance SF-2140 described in detail in the specification, and a pharmaceutically acceptable carrier. Also disclosed is a method for treatment of viral diseases comprising administering a pharmaceutically effective amount of the substance SF-2140.

Claims2

Dependent claims

A method for treatment of viral diseases which comprises administering a pharmaceutically effective amount of a substance SF-2140 represented by the following formula:

##STR4##

Dependencies are inferred from the claim text.

Facts

Application

06/624,786Filed 25 Jun 1984 · continuation in part

Priority

JP 57-18811628 Oct 1982

Granted

20 Aug 1985

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

C12N 1/205
Bacteria; Culture media therefor: bacterial isolates
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 31/16
For RNA viruses: for influenza or rhinoviruses
C07H 19/04
Sharing nitrogen: heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Antiviral agents

Life of this patent

Abstract

Claims2

Antiviral agents

Life of this patent

Abstract

Claims2